4//SEC Filing
Travis David L 4
Accession 0001127602-25-008403
CIK 0000877860other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 6:47 PM ET
Size
23.1 KB
Accession
0001127602-25-008403
Insider Transaction Report
Form 4
Travis David L
SVP/Chief Accounting Officer
Transactions
- Award
Common Stock
2025-03-03+5,500→ 21,555 total - Award
Stock Option (Right to Buy) 2025
2025-03-03+10,000→ 10,000 totalExercise: $73.34From: 2025-03-03Exp: 2030-03-03→ Common Stock (10,000 underlying) - Award
Stock Option (Right to Buy) 2025
2025-03-03+10,000→ 10,000 totalExercise: $73.34From: 2026-03-03Exp: 2030-03-03→ Common Stock (10,000 underlying) - Award
Stock Option (Right to Buy) 2025
2025-03-03+10,000→ 10,000 totalExercise: $73.34From: 2027-03-03Exp: 2030-03-03→ Common Stock (10,000 underlying)
Holdings
- 11,334
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2022-02-25Exp: 2026-02-25→ Common Stock (11,334 underlying) - 9,796
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2024-02-25Exp: 2027-02-25→ Common Stock (9,796 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2024-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 8,333
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2024-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying) - 8,334
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2026-02-23Exp: 2029-02-23→ Common Stock (8,334 underlying) - 11,666
Stock Options (Right to Buy) 2-25-2021
Exercise: $69.20From: 2021-02-25Exp: 2026-02-25→ Common Stock (11,666 underlying) - 2,404
Stock Option (Right to buy) 2022
Exercise: $53.41From: 2023-02-25Exp: 2027-02-25→ Common Stock (2,404 underlying) - 8,333
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2023-02-24Exp: 2028-02-24→ Common Stock (8,333 underlying) - 8,334
Stock Option (Right to Buy) 2023
Exercise: $54.73From: 2025-02-24Exp: 2028-02-28→ Common Stock (8,334 underlying) - 8,333
Stock Option (Right to Buy) 2024
Exercise: $57.76From: 2025-02-23Exp: 2029-02-23→ Common Stock (8,333 underlying)
Footnotes (1)
- [F1]These shares are restricted stock which vest 20% on each anniversary of the date of grant, starting March 3, 2026.
Documents
Issuer
NATIONAL HEALTH INVESTORS INC
CIK 0000877860
Entity typeother
Related Parties
1- filerCIK 0001685397
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 6:47 PM ET
- Size
- 23.1 KB